sads
thats perfect, thank you
lets hope it generates some further punts and discussion on the board
and someone wins the cheese
phaps i should have included one further question
v. if a licensing/co-devt deal, what is the headline value of all milestones
and as an example, to add to others,
Merck pays A$350M (upfront and milestones, plus royalties) for protease inhibitor from Ambrilia in October 2006 when in Phase I, and it ended up failing
so what will they pay for an efficacious, safe Phiii drug?!?
sadsthats perfect, thank youlets hope it generates some further...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)